For security purposes
FOR SECURITY PURPOSES - because Internet Explorer is no longer supported by Microsoft, we suggest that you interact with our secure site through one of our supported browsers - Google Chrome, Firefox, or MS Edge. If you continue to use this website with Internet Explorer you do so at your own risk and you may encounter problems.
search
Product Information
Phase Detail
Chirex 3126 (D)-penicillamine Phase
Chirex 3126 (D)-penicillamine Phase is recommended for the chiral LC separation of α-amino acids, their derivatives, α-hydroxy acids, and amino alcohols

Chirex 3126 (D)-penicillamine Phase

Chirex 3126 (D)-penicillamine ligand exchange chiral phase has an electron acceptor designed for the separation of:

  • α-amino acids, their derivatives
  • α-hydroxy acids, amino alcohols

Particle Size
5
Recommended Use
3126(d)-penicillamine.RecommendedUse

Documents

Type unfold_moreDocument Title unfold_more
No Data
Phenomenex logo
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.
CONNECT WITH US

PRODUCTS AND SERVICES

Products

Techniques

Industries

Quick Order

SUPPORT 

Product/Method Support

Product Troubleshooting

Contact Us

CQA / CofA


OUR COMPANY

About Phenomenex

News

Blog

Danaher Life Sciences


Terms and Conditions Privacy Statement Quality Policy Terms of Use Trademarks CA Supply Chains Act CA Consumer Privacy Act Cookie Policy Impressum © 2024 Phenomenex, Inc. All rights reserved.